Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2021 | Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non-Small-Cell Lung Cancer (MYSTIC) | CLINICAL LUNG CANCER |